Innoviva (INVA) Revenue (2011 - 2026)

Innoviva has reported Revenue for 16 years, with the latest figure at $98.0 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 10.56% year-over-year to $98.0 million; the trailing twelve-month figure through Mar 2026 stood at $307.2 million (up 9.99% YoY), and the FY2025 full-year result was $411.3 million, up 14.67% from the prior year.
• Revenue for Q1 2026 stood at $98.0 million, up from $1.1 million in the prior quarter.
• The five-year high for Revenue was $107.8 million in Q3 2025, with the low at $796000.0 in Q1 2023.
• Historically, Revenue has averaged $39.0 million across 5 years, with a median of $1.5 million in 2023.
• Annual changes were most pronounced in 2022 — Revenue tumbled 98.67% — and 2024, when it jumped 10093.67%.
• Innoviva's Revenue stood at $1.1 million in 2022, then jumped by 45.39% to $1.5 million in 2023, then slipped by 19.18% to $1.2 million in 2024, then decreased by 12.15% to $1.1 million in 2025, then soared by 8931.71% to $98.0 million in 2026.
• The last three Revenue figures came in at $98.0 million (Q1 2026), $1.1 million (Q4 2025), and $107.8 million (Q3 2025), per Business Quant data.